Search Results - "McNamara, Caroline J." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

by McNamara, Caroline J., Panzarella, Tony, Kennedy, James A., Arruda, Andrea, Claudio, Jaime O., Daher-Reyes, Georgina, Ho, Jenny, Siddiq, Nancy, Devlin, Rebecca, Tsui, Hubert, Su, Jie, Stockley, Tracy, Sukhai, Mahadeo, Kanwar, Nisha, Chan, Steven, Maze, Dawn, Schimmer, Aaron, Schuh, Andre, Sibai, Hassan, Viswabandya, Auro, Yee, Karen, Minden, Mark D., Kamel-Reid, Suzanne, Gupta, Vikas
Published in Blood advances (23.10.2018)

Get full text

Journal Article

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen

by Chen, Ruiqi, Liu, Xing, Law, Arjun D, Kanfar, Solaf, Maze, Dawn, Chan, Steven M, Gupta, Vikas, Yee, Karen W, Minden, Mark D, Schimmer, Aaron D, Schuh, Andre C, McNamara, Caroline J, Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan
Published in Current oncology (Toronto) (22.12.2020)

Get full text

Journal Article

Clinical Utility of Next‐generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single‐Center Experience

Clinical Utility of Next‐generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single‐Center Experience

by Alduaij, Waleed, McNamara, Caroline J., Schuh, Andre, Arruda, Andrea, Sukhai, Mahadeo, Kanwar, Nisha, Thomas, Mariam, Spiegel, Jay, Kennedy, James A., Stockley, Tracy, Tsui, Hubert, Devlin, Rebecca, Sibai, Hassan, Maze, Dawn, Schimmer, Aaron, Yee, Karen, Chan, Steven, Kamel‐Reid, Suzanne, Gupta, Vikas
Published in HemaSphere (01.06.2018)

Get full text

Journal Article

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

by Murphy, Tracy, Zou, Jinfeng, Daher-Reyes, Georgina S., Arruda, Andrea, Gupta, Vikas, McNamara, Caroline J., Minden, Mark D., Schimmer, Aaron D., Sibai, Hassan, Yee, Karen W.L., Korulla, Mariam, Stockley, Tracy, Kamel-Reid, Suzanne, Maze, Dawn, Tierens, Anne, Bratman, Scott V., Schuh, Andre C., Chan, Steven M.
Published in Blood advances (13.08.2019)

Get full text

Journal Article

Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series

Azacitidine and venetoclax for the treatment of accelerated and blast phase myeloproliferative neoplasms and chronic myelomonocytic leukemia: a case series

by Garcia-Horton, Alejandro, Maze, Dawn, McNamara, Caroline J., Sibai, Hassan, Gupta, Vikas, Murphy, Tracy
Published in Leukemia & lymphoma (12.05.2021)

Get full text

Journal Article

Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort

Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort

by England, James T., McNamara, Caroline J., Kennedy, James A., Capo-Chichi, Jose-Mario, Huang, Jingyue, Arruda, Andrea, Nye, Taylor, Cheung, Verna, Claudio, Jaime O., Maze, Dawn, Sibai, Hassan, Tierens, Anne, Tsui, Hubert, Bankar, Aniket, Xu, Wei, Stockley, Tracy, Gupta, Vikas
Published in Leukemia (01.06.2022)

Get full text

Journal Article

$Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms$

Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

by Murphy, Tracy, Mason, Jacqueline M., Leber, Brian, Bray, Mark R., Chan, Steven M., Gupta, Vikas, Khalaf, Dina, Maze, Dawn, McNamara, Caroline J., Schimmer, Aaron D., Schuh, Andre C., Sibai, Hassan, Trus, Michael, Valiquette, Debbie, Martin, Kylie, Nguyen, Linh, Li, Xuan, Mak, Tak W., Minden, Mark D., Yee, Karen W. L.
Published in Leukemia (01.03.2024)

Get full text

Journal Article

Enasidenib in Combination with Venetoclax in IDH2-Mutated Myeloid Malignancies: Preliminary Results of the Phase Ib/II Enaven-AML Trial

Enasidenib in Combination with Venetoclax in IDH2-Mutated Myeloid Malignancies: Preliminary Results of the Phase Ib/II Enaven-AML Trial

by Chan, Steven M, Cameron, Charina, Cathelin, Severine, Gupta, Vikas, Maze, Dawn, Minden, Mark D., Murphy, Tracy, Schimmer, Aaron D, Schuh, Andre C., Sibai, Hassan, Yee, Karen, DiNardo, Courtney D., McNamara, Caroline J
Published in Blood (23.11.2021)

Get full text

Journal Article

Preliminary Results from a Phase 1 Study of Cfi-400495, a PLK4 Inhibitor, in Patients with Acute Myeloid Leukemia and High Risk MDS

Preliminary Results from a Phase 1 Study of Cfi-400495, a PLK4 Inhibitor, in Patients with Acute Myeloid Leukemia and High Risk MDS

by Murphy, Tracy, Leber, Brian, Bray, Mark R, Chan, Steven M, Gupta, Vikas, Khalaf, Dina, Maze, Dawn, McNamara, Caroline J, Schimmer, Aaron D, Schuh, Andre C., Sibai, Hassan, Fletcher, Graham, Valiquette, Debbie, Martin, Kylie, Minden, Mark D., Yee, Karen W.L.
Published in Blood (05.11.2020)

Get full text

Journal Article

Geographical Distance from Quaternary Treatment Center Does Not Impact Choice of Upfront Therapy, Clinical Trial Participation and Outcomes in Patients with Newly Diagnosed AML

Geographical Distance from Quaternary Treatment Center Does Not Impact Choice of Upfront Therapy, Clinical Trial Participation and Outcomes in Patients with Newly Diagnosed AML

by Hershenfeld, Samantha A, Chan, Steven M, Gupta, Vikas, Maze, Dawn, McNamara, Caroline J, Minden, Mark D., Murphy, Tracy, Schuh, Andre C., Sibai, Hassan, Yee, Karen W.L., Schimmer, Aaron D
Published in Blood (05.11.2020)

Get full text

Journal Article

Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML): Princess Margaret Cancer Centre Experience

Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML): Princess Margaret Cancer Centre Experience

by Alhumaid, Muhned, Daher-Reyes, Georgina S, Lam, Wilson, Law, Arjun, Murphy, Tracy, McNamara, Caroline J, Yerushalmi, Gil, Schimmer, Aaron D, Schuh, Andre C., Maze, Dawn, Atenafu, Eshetu G, Yee, Karen W.L., Minden, Mark D., Chan, Steven M, Gupta, Vikas, Sibai, Hassan
Published in Blood (13.11.2019)

Get full text

Journal Article

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib

by Chen, Ruiqi, Liu, Xing, Kanfar, Solaf, Maze, Dawn, Chan, Steven M, Gupta, Vikas, Yee, Karen W.L., Minden, Mark D., Schimmer, Aaron D, Schuh, Andre C., McNamara, Caroline J, Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan
Published in Blood (13.11.2019)

Get full text

Journal Article

HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation

HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation

by Ho, Jenny M., Medeiros, Jessie J.F., Chan-Seng-Yue, Michelle, Hummel, Lauren, Arruda, Andrea, Mitchell, Amanda, McNamara, Caroline J, Kennedy, James A, Tierens, Anne, Maze, Dawn, Tsui, Hubert, Minden, Mark D., Gupta, Vikas, Dick, John E.
Published in Blood (13.11.2019)

Get full text

Journal Article

Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era

Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era

by Maze, Dawn, Arcasoy, Murat O., Henrie, Ryan, Cerquozzi, Sonia, Kamble, Rammurti, Al Hadidi, Samer, Yacoub, Abdulraheem, Elsawy, Mahmoud, Sirhan, Shireen, Singh, Anurag K., Smith, Elliot, Marcoux, Curtis, Werner, Dietrich, Greer, Wenda, Viswabandya, Auro, Daly, Andrew, Sibai, Hassan, McNamara, Caroline J, Xu, Wei, Lajkosz, Katherine, Foltz, Lynda, Gupta, Vikas
Published in Blood (05.11.2020)

Get full text

Journal Article

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA

by Murphy, Tracy, Ng, Stanley W.K., King, Ian, Zhang, Tong, Arruda, Andrea, Ibrahimova, Narmin, Claudio, Jaime O., Ferrera, Fiona, Pan, Kristele, Rockwell, Chantal, Lu, Zhibin, Stickle, Natalie, Virtanen, Carl, Gupta, Vikas, Maze, Dawn, McNamara, Caroline J, Schimmer, Aaron D, Schuh, Andre C., Sibai, Hassan, Yee, Karen W.L., Khalaf, Dina, Leber, Brian, Sabloff, Mitchell, Tierens, Anne, Minden, Mark D., Stockley, Tracy L., Chan, Steven M, Wang, Jean C.Y.
Published in Blood (05.11.2020)

Get full text

Journal Article

CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study

CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study

by Andrews, Claire, Young, Taylor, Atenafu, Eshetu G, Assouline, Sarit E, Brandwein, Joseph M, Chan, Steven M, Chow, Signy, Khalaf, Dina, Gupta, Vikas, Kim, Dennis Dong Hwan, Maze, Dawn, Minden, Mark D., McNamara, Caroline J, Murphy, Tracy, Sanford, David, Schimmer, Aaron D, Schuh, Andre C., Yee, Karen W.L., Sibai, Hassan
Published in Blood (05.11.2020)

Get full text

Journal Article

Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Harboring DNMT3A/TET2/ASXL1 Mutation

Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Harboring DNMT3A/TET2/ASXL1 Mutation

by Alhumaid, Muhned, Daher-Reyes, Georgina S., Schimmer, Aaron D, Schuh, Andre C., Tierens, Anne, McNamara, Caroline J, Maze, Dawn, Novitzky-Basso, Igor Nicolas, Yee, Karen W.L., Minden, Mark D., Chan, Steven M, Murphy, Tracy, Gupta, Vikas, Kim, Dennis Dong Hwan, Sibai, Hassan
Published in Blood (05.11.2020)

Get full text

Journal Article

Molecular Residual Disease Monitoring Provides Insufficient Lead-Time to Prevent Morphologic Relapse in the Majority of Patients with Core-Binding Factor AML

Molecular Residual Disease Monitoring Provides Insufficient Lead-Time to Prevent Morphologic Relapse in the Majority of Patients with Core-Binding Factor AML

by Puckrin, Robert, Atenafu, Eshetu G, Claudio, Jaime, Chan, Steven M, Gupta, Vikas, Maze, Dawn, McNamara, Caroline J, Minden, Mark D., Schuh, Andre, Murphy, Tracy, Sibai, Hassan, Yee, Karen W.L., Stockley, Tracy L., Kamel-Reid, Suzanne, Schimmer, Aaron D
Published in Blood (29.11.2018)

Get full text

Journal Article

Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

by Sibai, Hassan, Chen, Ruiqi, Liu, Xing, Schimmer, Aaron D, Schuh, Andre, Law, Arjun, McNamara, Caroline J, Maze, Dawn, Yee, Karen W.L., Minden, Mark D., Chan, Steven M, Gupta, Vikas, Murphy, Tracy, Falcone, Umberto, Sakurai, Naoko, Brandwein, Joseph M., Seki, Jack
Published in Blood (29.11.2018)

Get full text

Journal Article

Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations

Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations

by Murphy, Tracy, Zou, Jinfeng, Daher-Reyes, Georgina S, Gupta, Vikas, McNamara, Caroline J, Minden, Mark D., Schimmer, Aaron D, Sibai, Hassan, Yee, Karen W.L., Stockley, Tracy L., Kamel-Reid, Suzanne, Maze, Dawn, Bratman, Scott, Schuh, Andre, Chan, Steven M
Published in Blood (29.11.2018)

Get full text

Journal Article